Conservative Management for Retained Products of Conception in Late Pregnancy

被引:1
|
作者
Fujishima, Risa [1 ]
Kawasaki, Kaoru [1 ]
Moriuchi, Kaori [1 ]
Shiro, Reona [1 ]
Yo, Yoshie [1 ]
Matsumura, Noriomi [1 ]
机构
[1] Kindai Univ, Fac Med, Dept Obstet & Gynecol, 377-2 Ohno Higashi, Osakasayama, Osaka 5898511, Japan
关键词
retained products of conception (RPOC); postpartum hemorrhage; human chorionic gonadotropin (hCG); HUMAN CHORIONIC-GONADOTROPIN; MANUAL REMOVAL; PLACENTA;
D O I
10.3390/healthcare11020168
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This retrospective study aims to compare the early manual removal of placenta (MROP) and conservative management of retained products of conception (RPOC) after 34 weeks of gestation. Nineteen cases underwent MROP within 24 h of delivery, of which nine patients had no symptoms requiring emergent treatment. These 9 patients (group M) were compared with 22 patients who were treated conservatively (group C). Massive bleeding was observed in 5 (56%) patients in group M and 11 (50%) patients in group C, with no significant difference in frequency. However, the lowest hemoglobin level within 72 h after massive bleeding was lower in group M (median: 6.7 vs. 7.7 g/dL, p = 0.029), suggesting that massive bleeding occurred in a short period of time. On the other hand, a retained placenta was observed in four patients in group M after the MROP; however, the placenta disappeared more quickly than in group C (median; 1.0 vs. 99.0 days, p = 0.009). In group C, all bleeding and infection occurred within 60 days of delivery, including heavy bleeding in six cases during the placental-extraction trial. Human chorionic gonadotropin in group C fell below the measurable threshold at a median of 67 days postpartum. In conclusion, for RPOC without urgent symptoms, early MROP and conservative treatment have their advantages and disadvantages. Randomized controlled trials are needed to determine which of those treatments is superior.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Clinical Prediction of Retained Products of Conception: Combining Obstetric History and Ultrasound for Improved Accuracy in Severe Postpartum Hemorrhage
    Kurakazu, Mariko
    Kurakazu, Masamitsu
    Kiyoshima, Chihiro
    Shigekawa, Koichiro
    Hirakawa, Toyofumi
    Yoshikawa, Kenichi
    Ito, Tomohiro
    Urushiyama, Daichi
    Miyata, Kohei
    Yotsumoto, Fusanori
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [32] Retained products of conception in placenta previa without placenta accreta spectrum: who requires transarterial embolization and/or hysterectomy?
    Ohashi, Mai
    Takahashi, Hironori
    Baba, Yosuke
    Suzuki, Hirotada
    Nagayama, Shiho
    Horie, Kenji
    Ogoyama, Manabu
    Usui, Rie
    Ohkuchi, Akihide
    Matsubara, Shigeki
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (01)
  • [33] Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment
    Bazeries, Paul
    Paisant-Thouveny, Francine
    Yahya, Sultan
    Bouvier, Antoine
    Nedelcu, Cosmina
    Boussion, Francoise
    Sentilhes, Loic
    Willoteaux, Serge
    Aube, Christophe
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (04) : 520 - 529
  • [34] Removal of retained products of conception showing marked vascularity without uterine artery embolization: Two case reports
    Usui, Hirokazu
    Sato, Asuka
    Okayama, Jun
    Suzuki, Yoshiya
    Omoto, Akiko
    Shozu, Makio
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2018, 44 (08) : 1482 - 1486
  • [35] Ultrasonographic vascularity assessment for predicting future severe hemorrhage in retained products of conception after second-trimester abortion
    Akiba, Naoya
    Iriyama, Takayuki
    Nakayama, Toshio
    Seyama, Takahiro
    Sayama, Seisuke
    Kumasawa, Keiichi
    Komatsu, Atsushi
    Yabe, Shinichiro
    Nagamatsu, Takeshi
    Osuga, Yutaka
    Fujii, Tomoyuki
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2021, 34 (04) : 562 - 568
  • [36] Guideline for the Management of Conception and Pregnancy in Thalassaemia Syndromes: A British Society for Haematology Guideline
    Shah, Farrukh T.
    Nicolle, Sarah
    Garg, Mamta
    Pancham, Shivan
    Lieberman, Gidon
    Anthony, Karen
    Mensah, Amma Kyei
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (06) : 2194 - 2209
  • [37] Evaluation of retained products of conception using pulsed continuous arterial spin-labeling MRI: clinical feasibility and initial results
    Kosaka, Nobuyuki
    Fujiwara, Yasuhiro
    Kurokawa, Tetsuji
    Matsuda, Tsuyoshi
    Kanamoto, Masayuki
    Takei, Naoyuki
    Takata, Kenji
    Takahashi, Jin
    Yoshida, Yoshio
    Kimura, Hirohiko
    MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2018, 31 (04) : 577 - 584
  • [38] Fluorescent in situ hybridization:: an effective and less costly technique for genetic evaluation of products of conception in pregnancy losses
    Fejgin, MD
    Pomeranz, M
    Liberman, M
    Fishman, A
    Amiel, A
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2005, 84 (09) : 860 - 863
  • [39] Nitroglycerin for management of retained placenta
    Abdel-Aleem, Hany
    Abdel-Aleem, Mahmoud A.
    Shaaban, Omar M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [40] Intraumbilical injection of three different uterotonics in the management of retained placenta
    Harara, Rany
    Hanafy, Sherif
    Zidan, Mahmoud Saad Alsayed
    Alberry, Medhat
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2011, 37 (09) : 1203 - 1207